Leading lung cancer specialist Dr. Roy Herbst from Yale Cancer Center joins pathologists from Toronto and the UK, as well as Agilent Thought Leader Dr. Carlos Cardo-Cordon from Mount Sinai School of Medicine, to speak about the increasing importance of the pathologist in the multidisciplinary team of specialists that collaborate around each cancer patient. In the age of personalized medicine, they discuss how the diagnostic information provided by the pathologist is crucial for informing the therapeutic options and decisions that affect the future treatment of a cancer patient. To learn more from experts about how developments in drug research and development are creating new paradigms in the diagnosis and treatment of cancer, a new podcast on fighting cancer is also available to listen to in the podcast section of the newsroom.